| Literature DB >> 23861574 |
Sareaa Maseer Gatya Al-Mayahie1.
Abstract
Vaginal (61) and fecal (61) Escherichia coli isolates from pregnant and nonpregnant women (18-45 years old) were surveyed for papG alleles by PCR technique. papG allele II was the most prevalent among both vaginal (32.7%) and fecal (3.2%) isolates, whereas other alleles were found only among vaginal isolates (1.6% for alleles I and III and 3.2% for alleles II + III). papG(+) pregnant women's isolates did not differ significantly from those of nonpregnant in possession of papG allele II (90% versus 73.3%), whereas both (32.7%) differed significantly (P ≤ 0.05) in comparison with fecal isolates (3.2%). The vast majority of papG allele II(+) vaginal isolates were clustered in group B2 (81.8%) and much less in group D (18.1%). Also, most of them were positive for fimH (100%), papC (100%), iucC (90.9%), and hly (72.7%), and about half of them were positive for sfa/foc (45.4%). In addition, the mean of VFs' gene possession was 3.5 (range from 2 to 5). It can be concluded that vaginal colonization by papG allele II(+) E. coli is possibly one of the predisposing factors of both pregnant and nonpregnant women to pyelonephritis, but its potential may be modified by other factors especially host factors.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23861574 PMCID: PMC3703789 DOI: 10.1155/2013/860402
Source DB: PubMed Journal: Infect Dis Obstet Gynecol ISSN: 1064-7449
Nucleotide sequences of PCR primers used to amplify papG alleles [19].
| Gene | Primer sequence (5′-3′) | Amplicon |
|---|---|---|
|
| ||
| F | TCGTGCTCAGGTCCGGAATTT | 461 |
| R | TGGCATCCCCCAACATTATCG | |
|
| ||
| F | GGGATGAGCGGGCCTTTGAT | 190 |
| R | CGGGCCCCCAAGTAACTC | |
|
| ||
| F | GGCCTGCAATGGATTTACCTGG | 258 |
| R | CCACCAAATGACCATGCCAGA |
Nucleotide sequences of PCR primers used for phylogenetic grouping of E. coli [21].
| Gene | Primer sequence (5′-3′) | Amplicon size (bp) |
|---|---|---|
|
| ||
| F | GACGAACCAACGGTCAGGAT | 279 |
| R | TGCCGCCAGTACCAAAGACA | |
|
| ||
| F | TGAAGTGTCAGGAGACGCTG | 211 |
| R | ATGGAGAATGCGTTCCTCAAC | |
| TspE4.C2 | ||
| F | GAGTAATGTCGGGGCATTCA | 152 |
| R | CGCGCCAACAAAGTATTACG |
Nucleotide sequences of PCR primers used to amplify five ExPEC VFs.
| Gene | Primer sequence (5′-3′) | Amplicon size (bp) | Reference |
|---|---|---|---|
|
| |||
| F | AACAAGGATAAGCACTGTTCTGGCT | 1,177 |
[ |
| R | ACCATATAAGCGGTCATTCCCGTCA | ||
|
| |||
| F | GACGGCTGTACTGCAGGGTGTGGCG | 328 |
[ |
| R | ATATCCTTTCTGCAGGGATGCAATA | ||
|
| |||
| F | CTCCGGAGAACTGGGTGCATCTTAC | 410 |
[ |
| R | CGGAGGAGTAATTACAAACCTGGCA | ||
|
| |||
| F | AAACCTGGCTTACGCAACTGT | 269 |
[ |
| R | ACCCGTCTGCAAATCATGGAT | ||
|
| |||
| F | TGCAGAACGGATAAGCCGTGG | 508 |
[ |
| R | GCAGTCACCTGCCCTCCGGTA |
hly: alpha-hemolysin; papC: P fimbriae; sfa/foc: S fimbriae and F1C fimbriae; iucC: aerobactin; and fimH: type 1 fimbriae.
Distribution of papG alleles among vaginal and fecal E. coli isolates from pregnant and non-pregnant women.
| Source of isolates | Study individuals (no.) | No. (%) of isolates positive for | |||
|---|---|---|---|---|---|
| I | II | III | II + III | ||
| Vaginal | Pregnant (23) | 1 (4.3) | 9 (39.1) | 0 | 0 |
| Nonpregnant (38) | 0 | 11 (28.9) | 1 (2.6) | 2 (5.2) | |
|
| |||||
| Total (%) | (61) | 1 (1.6) | 20 (32.7) | 1 (1.6) | 2 (3.2) |
|
| |||||
| Fecal | Pregnant (30) | 0 | 2 (6.6) | 0 | 0 |
| Nonpregnant (31) | 0 | 0 | 0 | 0 | |
|
| |||||
| Total (%) | (61) | 0 | 2 (3.2) | 0 | 0 |
Phylogenetic groups and ExPEC VFs' genes possessed by papG + vaginal and fecal E. coli isolates from pregnant and nonpregnant women.
| Traits | No. (%) of isolates positive for the indicated trait | |||
|---|---|---|---|---|
| Vaginal isolates | Fecal isolates | |||
| Pregnant women's isolates ( | Nonpregnant women's isolates ( | Total ( | ( | |
| Phylogenetic groups | ||||
| A | 0 | 0 | 0 | 0 |
| B1 | 0 | 0 | 0 | 0 |
| B2 | 8 (80) | 11 (78.5) | 18 (78.2) | 0 |
| D | 2 (20) | 3 (21.4) | 5 (21.7) | 2 (100) |
| ExPEC VFs' genes | ||||
|
| 10 (100) | 14 (100) | 23 (100) | 2 (100) |
|
| 10 (100) | 14 (100) | 23 (100) | 2 (100) |
|
| 6 (60) | 7 (50.0) | 13 (56.5) | 0 |
|
| 7 (70) | 8 (57.1) | 15 (65.2) | 1 (50) |
|
| 9 (90) | 11 (78.5) | 20 (86.9) | 2 (100) |
Phylogenetic groups and ExPEC VFs' genes possessed by papG allele II+ vaginal and fecal E. coli isolates from pregnant and nonpregnant women.
| Traits | No. (%) of isolates positive for the indicated trait | |||
|---|---|---|---|---|
| Vaginal isolates | fecal isolates | |||
| Pregnant women's isolates ( | Nonpregnant women's isolates ( | Total ( | ( | |
| Phylogenetic groups | ||||
| A | 0 | 0 | 0 | 0 |
| B1 | 0 | 0 | 0 | 0 |
| B2 | 8 (88.8) | 10 (76.9) | 18 (81.8) | 0 |
| D | 1 (11.1) | 3 (23.0) | 4 (18.1) | 2 (100) |
| ExPEC VFs' genes | ||||
|
| 9 (100) | 13 (100) | 22 (100) | 2 (100) |
|
| 9 (100) | 13 (100) | 22 (100) | 2 (100) |
|
| 3 (33.3) | 7 (53.8) | 10 (45.4) | 0 |
|
| 7 (77.7) | 9 (69.2) | 16 (72.7) | 1 (50) |
|
| 9 (100) | 11 (84.6) | 20 (90.9) | 2 (100) |